Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
145.00
-3.26 (-2.20%)
At close: Dec 1, 2025, 4:00 PM EST
144.51
-0.49 (-0.34%)
After-hours: Dec 1, 2025, 7:48 PM EST
Molina Healthcare Stock Forecast
Stock Price Forecast
The 12 analysts that cover Molina Healthcare stock have a consensus rating of "Hold" and an average price target of $205.67, which forecasts a 41.84% increase in the stock price over the next year. The lowest target is $144 and the highest is $345.
Price Target: $205.67 (+41.84%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Buy | 6 | 3 | 3 | 3 | 3 | 3 |
| Hold | 9 | 10 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 14 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $231 → $165 | Buy | Maintains | $231 → $165 | +13.79% | Nov 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $207 → $167 | Hold | Maintains | $207 → $167 | +15.17% | Oct 24, 2025 |
| UBS | UBS | Hold Maintains $180 → $170 | Hold | Maintains | $180 → $170 | +17.24% | Oct 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $210 → $180 | Hold | Maintains | $210 → $180 | +24.14% | Oct 24, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $185 → $144 | Hold → Sell | Downgrades | $185 → $144 | -0.69% | Oct 24, 2025 |
Financial Forecast
Revenue This Year
45.25B
from 39.16B
Increased by 15.54%
Revenue Next Year
47.06B
from 45.25B
Increased by 3.99%
EPS This Year
15.04
from 20.42
Decreased by -26.37%
EPS Next Year
14.65
from 15.04
Decreased by -2.59%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.6B | 50.1B | |||
| Avg | 45.2B | 47.1B | |||
| Low | 43.4B | 43.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 10.7% | |||
| Avg | 15.5% | 4.0% | |||
| Low | 10.8% | -3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.87 | 22.14 | |||
| Avg | 15.04 | 14.65 | |||
| Low | 13.23 | 10.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.7% | 47.3% | |||
| Avg | -26.4% | -2.6% | |||
| Low | -35.2% | -28.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.